Global Flow Cytometry Market 2018-2019 & 2024: Focus on Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation & Hematology

DUBLIN, March 21, 2019 /PRNewswire/ — The “Flow Cytometry Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to’s offering.

The global flow cytometry market was valued at USD 303.51 million in 2018 and is estimated to reach USD 490.11 million in 2024, while witnessing a CAGR of 8.3% during the forecast period, 2019-2024.

The key factors propelling the market include the rise in the use of flow cytometry in stem cell research, the emergence and commercial application of new technologies in the field of flow cytometry, and rise in the applications of flow cytometry in clinical research.

There is a significance of flow cytometry in clinical research that is fueling the demand for flow cytometry techniques in R&D departments of the healthcare sector. The increasing incidences of HIV and cancer statistics show a significant unmet opportunity in cancer and AIDS diagnostics. There is a large void in diagnostics accessibility, particularly in the developing regions. Consequently, the increasing incidences of HIV AIDS and cancer can be considered a significant growth opportunity for the flow cytometry market.

Scope of the Report

Flow cytometry is a laser or an impedance-based technology, which is used in cell counting, detecting biomarker, cell sorting, and protein engineering, by suspending the cell in a stream of fluid and then passing them through a detection apparatus. It is the ideal tool to identify, characterize, and isolate stem and progenitor cells, for research and potential clinical use.

Key Market Trends

Stem Cell Therapy is Expected to Hold the Largest Market Share, by Application

The stem cell therapy segment is believed to have the largest market size and is expected to witness a CAGR of 8.4% during the forecast period.

The key reasons for the large market share include the extensive use of flow cytometry for effective diagnosis and early detection of numerous diseases that have helped the market to gain immense shares. There has been a growing market penetration in stem cell research, adoption of recombinant DNA technology for antibody production, and the evolution of tandem flow cytometry technologies that are expected to offer growth opportunities for the players operating in the flow cytometry market during the forecast period.

Though flow cytometry has also found many applications in several stages of drug discovery, its routine widespread use for high throughput drug screening has been limited. This is unlike analogous technology, automated high content imaging (HCI), which, in terms of drug screening, is an established technology that is common in screening laboratories.

North America Dominates the Market and is Expected to Continue its Lead over the Forecast Period

North America holds a major share of the flow cytometry market and is projected to continue over the next few years. An increasing prevalence of diseases and the rising contribution from the US market are expected to help the market grow. In addition, there has also been a rise in the expansion of novel products that are anticipated to offer new growth opportunities in the coming years.

Competitive Landscape

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players are holding a huge share of the market and are likely to remain in a similar competitive environment for the next few years. The rising importance of product development and the rise in R&D activities are projected to encourage the growth of the flow cytometry market.

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Use of Flow Cytometry in Stem Cell Research

4.2.2 Emergence and Commercial Applications of New Technologies in the Field of Flow Cytometry

4.2.3 Increasing Applications of Flow Cytometry in Clinical Research

4.3 Market Restraints

4.3.1 Lack of Awareness about the Potential Benefits of Flow Cytometry Techniques

4.3.2 Expensive Equipment

4.4 Industry Attractiveness – Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 Product Type

5.1.1 Instrument

5.1.2 Fluorophore

5.1.3 Kit and Reagent

5.1.4 Software

5.1.5 Other Product Types

5.2 Technology

5.2.1 Cell-based Flow Cytometry

5.2.2 Bead-based Flow Cytometry

5.3 Application

5.3.1 Oncology

5.3.2 Drug Discovery

5.3.3 Disease Diagnosis

5.3.4 Stem Cell Therapy

5.3.5 Organ Transplantation

5.3.6 Hematology

5.3.7 Other Applications

5.4 By End User

5.4.1 Hospitals and Clinics

5.4.2 Academia and Research Institutes

5.4.3 Pharmaceutical and Biotechnology Companies

5.4.4 Other End Users

5.5 Geography

5.5.1 North America US Canada Mexico

5.5.2 Europe Germany UK France Italy Spain Rest of Europe

5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific

5.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa

5.5.5 South America Brazil Argentina Rest of South America


6.1 Company Profiles

6.1.1 Becton, Dickinson and Company

6.1.2 Beckman Coulter

6.1.3 EMD Millipore (Merck KGaA)

6.1.4 Bio-Rad Laboratories

6.1.5 Luminex Corporation

6.1.6 Life Technologies

6.1.7 Miltenyi Biotech

6.1.8 Sysmex Partec GmbH

6.1.9 Agilent Technologies


For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links